Dr. R. Nicoletti and Prof. E. Compérat present the case against renaming Gleason score 6 in prostate cancer

In "Episode 4" of the series on "Present and future of diagnostics in Prostate Cancer", Dr. Rossella Nicoletti (IT) and Prof. Eva Compérat (FR) present the case against renaming Gleason score 6 Prostate Cancer. They discuss the strong pathological arguments for keeping the "cancer" designation, pointing to the morphological and molecular evidence that supports this classification. Prof. Comperat highlights the risks of causing confusion within the clinical and research communities if Gleason ...